Community control of helminth infections of man by mass and selective chemotherapy (Q39823222)

14 September 2017

1 reference

title

Community control of helminth infections of man by mass and selective chemotherapy (English)

1 reference

14 September 2017

1 reference

Anderson RM

1

1 reference

PubMed ID

3892436

14 September 2017

Medley GF

series ordinal

2

1 reference

14 September 2017

1 April 1985

1 reference

14 September 2017

1 reference

14 September 2017

90 ( Pt 4)

1 reference

14 September 2017

629-660

1 reference

Processes influencing the distribution of parasite numbers within host populations with special emphasis on parasite-induced host mortalities

14 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology?

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Evasion of the immune response: survival within low responder individuals of the host population.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Observations on the ability of repeated, light exposures to Schistosoma mansoni cercariae to induce resistance to reinfection in Kenyan baboons (Papio anubis).

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Effect Of Two-Month Interval Mass Chemotherapy On The Reinfection Of Ascaris Lumbricoides In Korea

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Population dynamics of human helminth infections: control by chemotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Comparative Efficacy Of Interval Mass Treatment On Ascaris Lumbricoides Infection In Korea

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Effect of targeted mass treatment on intensity of infection and morbidity in schistosomiasis mansoni. 3-year follow-up of a community in Machakos, Kenya.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Relationships between mortality, visual acuity and microfilarial load in the area of the Onchocerciasis Control Programme.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

The population biology and control of Ascaris lumbricoides in a rural community in Iran

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

On the longevity of Schistosoma mansoni in man on St. Lucia, West Indies

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Helminth infections of humans: mathematical models, population dynamics, and control.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

The dynamics of helminth infections, with special reference to schistosomes

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Hookworm burdens and faecal egg counts: an analysis of the biological basis of variation

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

Egg output stability and the epidemiology of Schistosoma haematobium Part II. An analysis of the epidemiology of endemic S. haematobium

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000052288

7 January 2021

10.1017/S0031182000052288

Identifiers

DOI

0 references

PubMed ID

3892436

1 reference

PubMed ID

3892436